[1]
|
Shors, T. (2013) Understanding Viruses. Jones & Bartlett Learning, Burlington.
|
[2]
|
Center for Disease Control (CDC) (2019) About HIV/AIDS.
https://www.cdc.gov/hiv/basics/whatishiv.html
|
[3]
|
Knipe, D.M. and Howley, P.M. (2013) Fields Virology. Wolters Kluwer/Lippincott Williams & Wilkins Health, Philadelphia.
|
[4]
|
Barre-Sinoussi, F., Ross, A.L. and Delfraissy, J.F. (2013) Past, Present and Future: 30 Years of HIV Research. Nature Reviews Microbiology, 11, 877-883.
https://doi.org/10.1038/nrmicro3132
|
[5]
|
Fields, B.N., Knipe, D.M., Howley, P.M. and Griffin, D.E. (2001) Fields Virology. Lippincott Williams & Wilkins, Philadelphia.
|
[6]
|
Healey, J. (2011) HIV and AIDS. Spinney Press, Thirroul.
|
[7]
|
Cockerell, C.J., Hall, B.J. and Hall, J.C. (2011) HIV/AIDS in the Post-HAART Era: Manifestations, Treatment, and Epidemiology. People’s Medical Publishing House USA Ltd. [PMPH], Shelton.
|
[8]
|
Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W. and Montagnier, L. (1983) Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS). Science, 220, 868-871.
https://doi.org/10.1126/science.6189183
|
[9]
|
World Health Organization (WHO) (2019) Data and Statistics.
https://www.who.int/hiv/data/en
|
[10]
|
Fettig, J., Swaminathan, M., Murrill, C.S. and Kaplan, J.E. (2014) Global Epidemiology of HIV. Infectious Disease Clinics of North America, 28, 323-337.
https://doi.org/10.1016/j.idc.2014.05.001
|
[11]
|
Coffin, J.M., Hughes, S.H. and Varmus, H. (1997) Retroviruses. Cold Spring Harbor Laboratory Press, Plainview.
|
[12]
|
Mahlknecht, U., Dichamp, I., Varin, A., Van Lint, C. and Herbein, G. (2008) NF-kappaB-Dependent Control of HIV-1 Transcription by the Second Coding Exon of Tat in T Cells. Journal of Leukocyte Biology, 83, 718-727.
https://doi.org/10.1189/jlb.0607405
|
[13]
|
Kinoshita, S., Chen, B.K., Kaneshima, H. and Nolan, G.P. (1998) Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells. Cell, 95, 595-604. https://doi.org/10.1016/S0092-8674(00)81630-X
|
[14]
|
National Institute of Health (NIH) (2019) HIV Treatment: The Basics: Understanding HIV/AIDS AIDSinfo.
|
[15]
|
Falkenhagen, A. and Joshi, S. (2018) Genetic Strategies for HIV Treatment and Prevention. Molecular Therapy—Nucleic Acids, 13, 514-533.
https://doi.org/10.1016/j.omtn.2018.09.018
|
[16]
|
Scherer, L., Rossi, J.J. and Weinberg, M.S. (2007) Progress and Prospects: RNA-Based Therapies for Treatment of HIV Infection. Gene Therapy, 14, 1057-1064.
https://doi.org/10.1038/sj.gt.3302977
|
[17]
|
Gu, W.G. (2015) Genome Editing-Based HIV Therapies. Trends in Biotechnology, 33, 172-179. https://doi.org/10.1016/j.tibtech.2014.12.006
|
[18]
|
Manning, G., Whyte, D.B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The Protein Kinase Complement of the Human Genome. Science, 298, 1912-1934.
https://doi.org/10.1126/science.1075762
|
[19]
|
Ubersax, J.A. and Ferrell, J.E. (2007) Mechanisms of Specificity in Protein Phosphorylation. Nature Reviews Molecular Cell Biology, 8, 530-541.
https://doi.org/10.1038/nrm2203
|
[20]
|
Schlessinger, J. (2014) Receptor Tyrosine Kinases: Legacy of the First Two Decades. Cold Spring Harbor Perspectives in Biology, 6, a008912.
https://doi.org/10.1101/cshperspect.a008912
|
[21]
|
Lachmann, A. and Ma’ayan, A. (2009) KEA: Kinase Enrichment Analysis. Bioinformatics, 25, 684-686. https://doi.org/10.1093/bioinformatics/btp026
|
[22]
|
Schor, S. and Einav, S. (2018) Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs. DNA and Cell Biology, 37, 63-69.
https://doi.org/10.1089/dna.2017.4033
|
[23]
|
De Clercq, E. and Li, G. (2016) Approved Antiviral Drugs over the Past 50 Years. Clinical Microbiology Reviews, 29, 695-747. https://doi.org/10.1128/CMR.00102-15
|
[24]
|
Boison, D. (2013) Adenosine Kinase: Exploitation for Therapeutic Gain. Pharmacological Reviews, 65, 906-943. https://doi.org/10.1124/pr.112.006361
|
[25]
|
Linden, J. (2005) Adenosine in Tissue Protection and Tissue Regeneration. Molecular Pharmacology, 67, 1385-1387. https://doi.org/10.1124/mol.105.011783
|
[26]
|
NIH U.S. National Library of Medicine (2019) Home—ClinicalTrials.gov.
|
[27]
|
Manning, B.D. and Cantley, L.C. (2007) AKT/PKB Signaling: Navigating Downstream. Cell, 129, 1261-1274. https://doi.org/10.1016/j.cell.2007.06.009
|
[28]
|
Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M. and Donner, D.B. (1999) NF-kappaB Activation by Tumour Necrosis Factor Requires the Akt Serine-Threonine Kinase. Nature, 401, 82-85. https://doi.org/10.1038/43466
|
[29]
|
Brass, A.L., Dykxhoorn, D.M., Benita, Y., Yan, N., Engelman, A., Xavier, R.J., Lieberman, J. and Elledge, S.J. (2008) Identification of Host Proteins Required for HIV Infection through a Functional Genomic Screen. Science, 319, 921-926.
https://doi.org/10.1126/science.1152725
|
[30]
|
Zhou, H., Xu, M., Huang, Q., Gates, A.T., Zhang, X.D., Castle, J.C., Stec, E., Ferrer, M., Strulovici, B., Hazuda, D.J. and Espeseth, A.S. (2008) Genome-Scale RNAi Screen for Host Factors Required for HIV Replication. Cell Host Microbe, 4, 495-504. https://doi.org/10.1016/j.chom.2008.10.004
|
[31]
|
Nehme, Z., Pasquereau, S. and Herbein, G. (2019) Control of Viral Infections by Epigenetic-Targeted Therapy. Clinical Epigenetics, 11, 55.
https://doi.org/10.1186/s13148-019-0654-9
|
[32]
|
Pasquereau, S., Kumar, A., Abbas, W. and Herbein, G. (2018) Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages. Viruses, 10, 190. https://doi.org/10.3390/v10040190
|
[33]
|
Krejsgaard, T., Vetter-Kauczok, C.S., Woetmann, A., Kneitz, H., Eriksen, K.W., Lovato, P., Zhang, Q., Wasik, M.A., Geisler, C., Ralfkiaer, E., Becker, J.C. and Odum, N. (2009) Ectopic Expression of B-Lymphoid Kinase in Cutaneous T-Cell Lymphoma. Blood, 113, 5896-5904. https://doi.org/10.1182/blood-2008-09-181024
|
[34]
|
Konig, R., Zhou, Y., Elleder, D., Diamond, T.L., Bonamy, G.M., Irelan, J.T., Chiang, C.Y., Tu, B.P., De Jesus, P.D., Lilley, C.E., Seidel, S., Opaluch, A.M., Caldwell, J.S., Weitzman, M.D., Kuhen, K.L., Bandyopadhyay, S., Ideker, T., Orth, A.P., Miraglia, L.J., Bushman, F.D., Young, J.A. and Chanda, S.K. (2008) Global Analysis of Host-Pathogen Interactions That Regulate Early-Stage HIV-1 Replication. Cell, 135, 49-60. https://doi.org/10.1016/j.cell.2008.07.032
|
[35]
|
Edwards, M.C., Wong, C. and Elledge, S.J. (1998) Human Cyclin K, a Novel RNA Polymerase II-Associated Cyclin Possessing Both Carboxy-Terminal Domain Kinase and Cdk-Activating Kinase Activity. Molecular and Cellular Biology, 18, 4291-4300.
https://doi.org/10.1128/MCB.18.7.4291
|
[36]
|
Baek, K., Brown, R.S., Birrane, G. and Ladias, J.A. (2007) Crystal Structure of Human Cyclin K, a Positive Regulator of Cyclin-Dependent Kinase 9. Journal of Molecular Biology, 366, 563-573. https://doi.org/10.1016/j.jmb.2006.11.057
|
[37]
|
Khan, S.Z. and Mitra, D. (2011) Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cyclin-Dependent Kinase 9 (CDK9)-Cyclin T1 Interaction in Nef-Dependent Manner. The Journal of Biological Chemistry, 286, 22943-22954.
https://doi.org/10.1074/jbc.M110.201194
|
[38]
|
Sadler, A.J. and Williams, B.R. (2007) Structure and Function of the Protein Kinase R. Current Topics in Microbiology and Immunology, 316, 253-292.
https://doi.org/10.1007/978-3-540-71329-6_13
|
[39]
|
Burgess, H.M. and Mohr, I. (2015) Cellular 5’-3’ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses. Cell Host Microbe, 17, 332-344. https://doi.org/10.1016/j.chom.2015.02.003
|
[40]
|
Cai, R., Carpick, B., Chun, R.F., Jeang, K.T. and Williams, B.R. (2000) HIV-I TAT Inhibits PKR Activity by Both RNA-Dependent and RNA-Independent Mechanisms. Archives of Biochemistry and Biophysics, 373, 361-367.
https://doi.org/10.1006/abbi.1999.1583
|
[41]
|
Yoon, C.H., Kim, S.Y., Byeon, S.E., Jeong, Y., Lee, J., Kim, K.P., Park, J. and Bae, Y.S. (2015) p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation. Journal of Virology, 89, 4262-4280.
https://doi.org/10.1128/JVI.03087-14
|
[42]
|
Sanghvi, V.R. and Steel, L.F. (2011) The Cellular TAR RNA Binding Protein, TRBP, Promotes HIV-1 Replication Primarily by Inhibiting the Activation of Double-Stranded RNA-Dependent Kinase PKR. Journal of Virology, 85, 12614-12621.
https://doi.org/10.1128/JVI.05240-11
|
[43]
|
Clerzius, G., Gelinas, J.F., Daher, A., Bonnet, M., Meurs, E.F. and Gatignol, A. (2009) ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication. Journal of Virology, 83, 10119-10128.
https://doi.org/10.1128/JVI.02457-08
|
[44]
|
Guccione, M., Ettari, R., Taliani, S., Da Settimo, F., Zappala, M. and Grasso, S. (2016) G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. Journal of Medicinal Chemistry, 59, 9277-9294.
https://doi.org/10.1021/acs.jmedchem.5b01939
|
[45]
|
Asai, D., Murata, M., Toita, R., Kawano, T., Nakashima, H. and Kang, J.H. (2016) Role of Amino Acid Residues Surrounding the Phosphorylation Site in Peptide Substrates of G Protein-Coupled Receptor Kinase 2 (GRK2). Amino Acids, 48, 2875-2880.
https://doi.org/10.1007/s00726-016-2345-6
|
[46]
|
Lock, P., Ralph, S., Stanley, E., Boulet, I., Ramsay, R. and Dunn, A.R. (1991) Two Isoforms of Murine Hck, Generated by Utilization of Alternative Translational Initiation Codons, Exhibit Different Patterns of Subcellular Localization. Molecular and Cellular Biology, 11, 4363-4370. https://doi.org/10.1128/MCB.11.9.4363
|
[47]
|
Ziegler, S.F., Marth, J.D., Lewis, D.B. and Perlmutter, R.M. (1987) Novel Protein-Tyrosine Kinase Gene (hck) Preferentially Expressed in Cells of Hematopoietic Origin. Molecular and Cellular Biology, 7, 2276-2285.
https://doi.org/10.1128/MCB.7.6.2276
|
[48]
|
Poh, A.R., O’Donoghue, R.J. and Ernst, M. (2015) Hematopoietic Cell Kinase (HCK) as a Therapeutic Target in Immune and Cancer Cells. Oncotarget, 6, 15752-15771.
https://doi.org/10.18632/oncotarget.4199
|
[49]
|
Trible, R.P., Emert-Sedlak, L. and Smithgall, T.E. (2006) HIV-1 Nef Selectively Activates Src Family Kinases Hck, Lyn, and c-Src through Direct SH3 Domain Interaction. The Journal of Biological Chemistry, 281, 27029-27038.
https://doi.org/10.1074/jbc.M601128200
|
[50]
|
Lee, J.H., Ostalecki, C., Zhao, Z., Kesti, T., Bruns, H., Simon, B., Harrer, T., Saksela, K. and Baur, A.S. (2018) HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles. EBioMedicine, 28, 151-161.
https://doi.org/10.1016/j.ebiom.2018.01.004
|
[51]
|
Lambert, A.A., Gilbert, C., Richard, M., Beaulieu, A.D. and Tremblay, M.J. (2008) The C-Type Lectin Surface Receptor DCIR Acts as a New Attachment Factor for HIV-1 in Dendritic Cells and Contributes to Trans- and Cis-Infection Pathways. Blood, 112, 1299-1307. https://doi.org/10.1182/blood-2008-01-136473
|
[52]
|
Lambert, A.A., Barabe, F., Gilbert, C. and Tremblay, M.J. (2011) DCIR-Mediated Enhancement of HIV-1 Infection Requires the ITIM-Associated Signal Transduction Pathway. Blood, 117, 6589-6599.
https://doi.org/10.1182/blood-2011-01-331363
|
[53]
|
Hassaine, G., Courcoul, M., Bessou, G., Barthalay, Y., Picard, C., Olive, D., Collette, Y., Vigne, R. and Decroly, E. (2001) The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral vif Protein. The Journal of Biological Chemistry, 276, 16885-16893. https://doi.org/10.1074/jbc.M009076200
|
[54]
|
Gallo, K.A., Mark, M.R., Scadden, D.T., Wang, Z., Gu, Q. and Godowski, P.J. (1994) Identification and Characterization of SPRK, a Novel src-Homology 3 Domain-Containing Proline-Rich Kinase with Serine/Threonine Kinase Activity. The Journal of Biological Chemistry, 269, 15092-15100.
|
[55]
|
Tibbles, L.A., Ing, Y.L., Kiefer, F., Chan, J., Iscove, N., Woodgett, J.R. and Lassam, N.J. (1996) MLK-3 Activates the SAPK/JNK and p38/RK Pathways via SEK1 and MKK3/6. The EMBO Journal, 15, 7026-7035.
https://doi.org/10.1002/j.1460-2075.1996.tb01094.x
|
[56]
|
Amako, Y., Igloi, Z., Mankouri, J., Kazlauskas, A., Saksela, K., Dallas, M., Peers, C. and Harris, M. (2013) Hepatitis C Virus NS5A Inhibits Mixed Lineage Kinase 3 to Block Apoptosis. The Journal of Biological Chemistry, 288, 24753-24763.
https://doi.org/10.1074/jbc.M113.491985
|
[57]
|
Nguyen, D.G., Yin, H., Zhou, Y., Wolff, K.C., Kuhen, K.L. and Caldwell, J.S. (2007) Identification of Novel Therapeutic Targets for HIV Infection through Functional Genomic cDNA Screening. Virology, 362, 16-25.
https://doi.org/10.1016/j.virol.2006.11.036
|
[58]
|
Yuan, X., Wu, H., Bu, H., Zhou, J. and Zhang, H. (2019) Targeting the Immunity Protein Kinases for Immuno-Oncology. European Journal of Medicinal Chemistry, 163, 413-427. https://doi.org/10.1016/j.ejmech.2018.11.072
|
[59]
|
Klatt, A., Zhang, Z., Kalantari, P., Hankey, P.A., Gilmour, D.S. and Henderson, A.J. (2008) The Receptor Tyrosine Kinase RON Represses HIV-1 Transcription by Targeting RNA Polymerase II Processivity. The Journal of Immunology, 180, 1670-1677.
https://doi.org/10.4049/jimmunol.180.3.1670
|
[60]
|
Manser, E., Leung, T., Salihuddin, H., Zhao, Z.S. and Lim, L. (1994) A Brain Serine/Threonine Protein Kinase Activated by Cdc42 and Rac1. Nature, 367, 40-46.
https://doi.org/10.1038/367040a0
|
[61]
|
Huang, H.W., Zhang, X.Y., Song, P.L., Jiang, H.L., Li, W., Wang, P.L., Wang, J. and Liu, F.N. (2018) Old Drug New Tricks: Chlorhexidine Acts as a Potential Allosteric Inhibitor toward PAK1. Biochemical and Biophysical Research Communications, 495, 728-732. https://doi.org/10.1016/j.bbrc.2017.11.087
|
[62]
|
Fackler, O.T., Lu, X., Frost, J.A., Geyer, M., Jiang, B., Luo, W., Abo, A., Alberts, A.S. and Peterlin, B.M. (2000) p21-Activated Kinase 1 Plays a Critical Role in Cellular Activation by Nef. Molecular and Cellular Biology, 20, 2619-2627.
https://doi.org/10.1128/MCB.20.7.2619-2627.2000
|
[63]
|
Kouwenhoven, A., Minassian, V.D. and Marsh, J.W. (2013) HIV-1 Nef Mediates Pak Phosphorylation of Mek1 serine298 and Elicits an Active Phospho-State of Pak2. Current HIV Research, 11, 198-209.
https://doi.org/10.2174/1570162X113119990039
|
[64]
|
Nguyen, D.G., Wolff, K.C., Yin, H., Caldwell, J.S. and Kuhen, K.L. (2006) “UnPAKing” Human Immunodeficiency Virus (HIV) Replication: Using Small Interfering RNA Screening to Identify Novel Cofactors and Elucidate the Role of Group I PAKs in HIV Infection. Journal of Virology, 80, 130-137.
https://doi.org/10.1128/JVI.80.1.130-137.2006
|
[65]
|
Popik, W. and Pitha, P.M. (1996) Binding of Human Immunodeficiency Virus Type 1 to CD4 Induces Association of Lck and Raf-1 and Activates Raf-1 by a Ras-Independent Pathway. Molecular and Cellular Biology, 16, 6532-6541.
https://doi.org/10.1128/MCB.16.11.6532
|
[66]
|
Berridge, M.J. (2014) Module 2: Cell Signalling Pathways. Cell Signalling Biology, 6, csb0001002. https://doi.org/10.1042/csb0001002
|
[67]
|
Finco, T.S. and Baldwin, A.S. (1993) Kappa B Site-Dependent Induction of Gene Expression by Diverse Inducers of Nuclear Factor Kappa B Requires Raf-1. The Journal of Biological Chemistry, 268, 17676-17679.
|
[68]
|
Gringhuis, S.I., van der Vlist, M., van den Berg, L.M., den Dunnen, J., Litjens, M. and Geijtenbeek, T.B. (2010) HIV-1 Exploits Innate Signaling by TLR8 and DC-SIGN for Productive Infection of Dendritic Cells. Nature Immunology, 11, 419-426.
https://doi.org/10.1038/ni.1858
|
[69]
|
Deindl, S., Kadlecek, T.A., Brdicka, T., Cao, X., Weiss, A. and Kuriyan, J. (2007) Structural Basis for the Inhibition of Tyrosine Kinase Activity of ZAP-70. Cell, 129, 735-746.
https://doi.org/10.1016/j.cell.2007.03.039
|
[70]
|
Wang, H., Kadlecek, T.A., Au-Yeung, B.B., Goodfellow, H.E., Hsu, L.Y., Freedman, T.S. and Weiss, A. (2010) ZAP-70: An Essential Kinase in T-Cell Signaling. Cold Spring Harbor Perspectives in Biology, 2, a002279.
https://doi.org/10.1101/cshperspect.a002279
|
[71]
|
Arpaia, E., Shahar, M., Dadi, H., Cohen, A. and Roifman, C.M. (1994) Defective T Cell Receptor Signaling and CD8+ Thymic Selection in Humans Lacking Zap-70 Kinase. Cell, 76, 947-958. https://doi.org/10.1016/0092-8674(94)90368-9
|
[72]
|
Elder, M.E., Lin, D., Clever, J., Chan, A.C., Hope, T.J., Weiss, A. and Parslow, T.G. (1994) Human Severe Combined Immunodeficiency Due to a Defect in ZAP-70, a T Cell Tyrosine Kinase. Science, 264, 1596-1599.
https://doi.org/10.1126/science.8202712
|
[73]
|
Meinl, E., Lengenfelder, D., Blank, N., Pirzer, R., Barata, L. and Hivroz, C. (2000) Differential Requirement of ZAP-70 for CD2-Mediated Activation Pathways of Mature Human T Cells. The Journal of Immunology, 165, 3578-3583.
https://doi.org/10.4049/jimmunol.165.7.3578
|
[74]
|
Tardif, M.R. and Tremblay, M.J. (2005) Regulation of LFA-1 Activity through Cytoskeleton Remodeling and Signaling Components Modulates the Efficiency of HIV Type-1 Entry in Activated CD4+ T Lymphocytes. The Journal of Immunology, 175, 926-935. https://doi.org/10.4049/jimmunol.175.2.926
|
[75]
|
Sol-Foulon, N., Sourisseau, M., Porrot, F., Thoulouze, M.I., Trouillet, C., Nobile, C., Blanchet, F., di Bartolo, V., Noraz, N., Taylor, N., Alcover, A., Hivroz, C. and Schwartz, O. (2007) ZAP-70 Kinase Regulates HIV Cell-to-Cell Spread and Virological Synapse Formation. The EMBO Journal, 26, 516-526.
https://doi.org/10.1038/sj.emboj.7601509
|